Ahead Of The Curve: Cystic Fibrosis

eCystic Fibrosis Review: How to Interpret Genetic Tests for Cystic Fibrosis

eCystic Fibrosis Review:Emerging Pathogens in Cystic Fibrosis

eCystic Fibrosis Review:Measurement of Early Lung Disease in Children With Cystic Fibrosis

eCystic Fibrosis Review:Featured Cases: Cystic Fibrosis–Related Diabetes

eCystic Fibrosis Review:Featured Cases: Nutritional Challenges and Complications in Patients with CF

eCystic Fibrosis Review: Featured Cases: Vitamin D and Bone Health

Featured Cases: State-of-the-Art Treatment for CF Lung Disease

eCystic Fibrosis Review: Featured Cases: New Inhalation Therapies

eCystic Fibrosis Review: Featured Cases: Modifiers of CF Lung Disease

eCystic Fibrosis Review: Featured Cases: Interventions to Improve Nutrition in Patients with CF

eCystic Fibrosis Review: Featured Cases: The Role of Exercise and Physical Activity in Optimizing Outcomes Among Patients with CF

eCystic Fibrosis Review: Adherence to Chronic Inhaled Therapies

P. aeruginosa Eradication

Presented at NACFC Anaheim 2011 this symposium presentation offers information on the current treatment options for patients with cystic fibrosis. Mike Boyle, MD, from Johns Hopkins University School of Medicine offers a 25-minute look at the basics of CF, then describes genotype and CF phenotype relationships. The presentation includes a review the influences of severity of lung disease and outcomes in CF, followed up by issues related to adherence.

Presented at NACFC Anaheim 2011 this symposium presentation offers information on the current treatment options for patients with cystic fibrosis. Mike Boyle, MD, from Johns Hopkins University School of Medicine offers a 25-minute look at the basics of CF, then describes genotype and CF phenotype relationships. The presentation includes a review the influences of severity of lung disease and outcomes in CF, followed up by issues related to adherence.

Presented at NACFC Anaheim 2011 this symposium presentation offers information on the current treatment options for patients with cystic fibrosis. Mike Boyle, MD, from Johns Hopkins University School of Medicine offers a 25-minute look at the basics of CF, then describes genotype and CF phenotype relationships. The presentation includes a review the influences of severity of lung disease and outcomes in CF, followed up by issues related to adherence.

This program describes the correlation between a patient’s CFTR genotype and their CF phenotype, explains the importance of genetic testing in suspected adult-onset CF, and identifies the practical uses of the CFTR2 database.

Leading experts address the current evidence-based best practices, with educational and inspirational sessions on adherence, originally presented at the 29th North American Cystic Fibrosis Conference.

Hear from Francis Collins, Tsui Lap-Chee, and Jack Riordan whose labs worked together to discover the CF gene. CF luminaries Bob Beall, Pamela Davis, Philip M. Farrell and others share how the discovery of the CF gene changed everything. Faculty present the clinical data and how patient care is evolving.

Meet Daniel, a three-year-old whose routine throat culture just grew P. aeruginosa, originally presented at the 28th North American Cystic Fibrosis Conference.